44 related articles for article (PubMed ID: 1285061)
1. Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis.
Griffin JD; Christopher MA; Thati S; Salash JR; Pressnall MM; Weerasekara DB; Lunte SM; Berkland CJ
Mol Pharm; 2019 Feb; 16(2):607-617. PubMed ID: 30615457
[TBL] [Abstract][Full Text] [Related]
2. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain AC; Wallace RP; Lorentz KM; Thornley TB; Antane JT; Raczy MR; Reda JW; Alpar AT; Slezak AJ; Watkins EA; Maulloo CD; Budina E; Solanki A; Nguyen M; Bischoff DJ; Harrington JL; Mishra R; Conley GP; Marlin R; Dereuddre-Bosquet N; Gallouët AS; LeGrand R; Wilson DS; Kontos S; Hubbell JA
Nat Biomed Eng; 2023 Sep; 7(9):1142-1155. PubMed ID: 37679570
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.
Podojil JR; Miller SD
Immunol Rev; 2009 May; 229(1):337-55. PubMed ID: 19426232
[TBL] [Abstract][Full Text] [Related]
4. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.
Turley DM; Miller SD
Results Probl Cell Differ; 2010; 51():217-35. PubMed ID: 19130025
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease.
Podojil JR; Turley DM; Miller SD
Adv Exp Med Biol; 2008; 640():234-51. PubMed ID: 19065796
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis.
Zhang H; Podojil JR; Luo X; Miller SD
J Immunol; 2008 Oct; 181(7):4638-47. PubMed ID: 18802066
[TBL] [Abstract][Full Text] [Related]
7. Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis.
Yang JS; Xu LY; Huang YM; Van Der Meide PH; Link H; Xiao BG
Immunology; 2000 Nov; 101(3):397-403. PubMed ID: 11106944
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.
Delaney CP; Murase N; Chen-Woan M; Fung JJ; Starzl TE; Demetris AJ
J Clin Invest; 1996 Jan; 97(1):217-25. PubMed ID: 8550837
[TBL] [Abstract][Full Text] [Related]
9. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
Dal Canto MC; Melvold RW; Kim BS; Miller SD
Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856
[TBL] [Abstract][Full Text] [Related]
10. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of CD4+ T cell responses to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice.
McRae BL; Miller SD
Neurochem Res; 1994 Aug; 19(8):997-1004. PubMed ID: 7528357
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
Tan LJ; Kennedy MK; Miller SD
J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses.
Kennedy MK; Clatch RJ; Dal Canto MC; Trotter JL; Miller SD
J Neuroimmunol; 1987 Nov; 16(3):345-64. PubMed ID: 2444626
[TBL] [Abstract][Full Text] [Related]
15. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.
Miller SD; Tan LJ; Pope L; McRae BL; Karpus WJ
Int Rev Immunol; 1992; 9(3):203-22. PubMed ID: 1285061
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
Pope L; Paterson PY; Miller SD
J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
